Topics in focus 2025 The International Journal of Clinical Pharmacology and Therapeutics [0.03%]
焦点话题 2025年《临床药理与治疗杂志》
Barrington G Woodcock-Kloberdanz
Barrington G Woodcock-Kloberdanz
Warfarin pharmacokinetics and pharmacodynamics are not affected by concomitant administration of the long-acting GLP-1 receptor agonist polyethylene glycol loxenatide [0.03%]
长效GLP-1受体激动剂聚乙二醇洛塞那肽合用不影响华法林的药动学和药效学
Huili Zhou,Guolan Wu,Duo Lv et al.
Huili Zhou et al.
Objective: To evaluate potential drug-drug interactions between polyethylene glycol loxenatide (PEX-168) and warfarin. Materials and methods: ...
Immune checkpoint inhibitors: A bibliometric analysis of research trends and hotspots based on the most frequently cited clinical trials (2013 - 2021) [0.03%]
基于高被引临床试验(2013-2021年)的免疫检查点抑制剂研究趋势和热点的文献计量分析
Peixiang Wang,Liping Zhao,Lihua Jia et al.
Peixiang Wang et al.
Objective: To quantitatively and qualitatively evaluate research trends and hotspots for immune checkpoint inhibitors (ICIs), according to the most frequently cited clinical trials. ...
Aplastic anemia associated with osimertinib: Analysis of the FDA adverse event reporting system [0.03%]
奥斯替尼相关再生障碍性贫血的FDA不良事件报道系统分析
Katsuhiro Ohyama,Seiichiro Katagiri,Satoshi Takahashi et al.
Katsuhiro Ohyama et al.
Objective: Aplastic anemia (AA) is a life-threatening disease, and drug-induced AA is rare. Recently, studies on cases that possibly developed AA following osimertinib treatment have been conducted. This study evaluated t...
The association between alphablockers in the treatment of benign prostatic hyperplasia and heart failure: A nationwide population-based cohort study in South Korea [0.03%]
韩国全国人群队列研究中治疗良性前列腺增生的α1受体阻滞剂与心力衰竭之间的关联性研究
Ji-Young Jeong,Mu Kyung Kim,Ju-Young Shin
Ji-Young Jeong
Background and objectives: This study aimed to determine whether there is an association between the use of α-blockers to treat benign prostatic hyperplasia (BPH) and the development of heart failure in elderly Asian pat...
Pharmacokinetics and bioequivalence of ezetimibe tablet in healthy Chinese subjects under fasting and fed conditions [0.03%]
在空腹及餐后条件下在中国健康受试者中依折麦布片的药代动力学及生物等效性
Guan Liu,Hegui Yan,Baodong Yuan et al.
Guan Liu et al.
Objective: The purpose of this study is to evaluate the pharmacokinetics (PK) parameters of an ezetimibe 10 mg (test drug) and assess its bioequivalence to the branded reference product in healthy Chinese subjects under f...
Randomized Controlled Trial
International journal of clinical pharmacology and therapeutics. 2025 Jan;63(1):38-46. DOI:10.5414/CP204642 2025
Corrigendum for the article Int J Clin Pharmacol Ther 2024; 11: 525-533 [0.03%]
对文章“Int J Clin Pharmacol Ther 2024; 11: 525-533”的勘误声明
Megumi Ikura,Tsutomu Nakamura,Kyoichi Wada et al.
Megumi Ikura et al.
Voriconazole trough levels after switching from an intravenous to oral formulation in a patient with short bowel syndrome [0.03%]
短肠综合征患者从静脉给药改为口服给药后的伏立康唑谷浓度监测
Rumi Ishida,Takeo Yasu,Mieko Hayakawa et al.
Rumi Ishida et al.
Association between trough plasma voriconazole concentration and adverse drug reactions in elderly patients [0.03%]
伏立康唑谷浓度与老年患者药物不良反应的相关性分析
Xiaolei Hu,Min Tang,Ling Tang et al.
Xiaolei Hu et al.
Objective: Only limited data are available on trough plasma voriconazole concentration in elderly patients. This study aimed to assess the association between voriconazole concentration and adverse drug reactions (ADR). ...
Sophia Kisters,Klaus Kisters,Tanja Werner et al.
Sophia Kisters et al.
Introduction: Recent data show that magnesium supplementation decreases systolic and diastolic blood pressure values depending on the blood pressure levels and improves metabolic parameters in cardiovascular disease. ...
Randomized Controlled Trial
International journal of clinical pharmacology and therapeutics. 2024 Dec;62(12):569-578. DOI:10.5414/CP204677 2024